Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight

Minister of Tourism Inaugurates ‘Rixos Murjana’, Saudi Arabia’s Largest Ultra All-Inclusive Resort, Enabled by the Tourism Development Fund, the Project’s Financier and Investor

SeaPak Reframes Lent as a Season of Discovery, Helping Families Say ‘Yes!’ to Seafood

Grünenthal’s proprietary NaV 1.8 inhibitor enters clinical development